Integrated safety analysis of anti-programmed cell death-1 (PD-1) antibody penpulimab in advanced solid tumour or lymphoma

被引：0

作者：

Xu, N. ^{[1
]}

Han, B. ^{[2
]}

Jiao, S. ^{[3
]}

Hu, C. ^{[4
]}

Mislang, A. ^{[5
]}

Coward, J. ^{[6
]}

Cooper, A. ^{[7
]}

Underhill, C. ^{[8
]}

Xia, Y. ^{[9
]}

Xia, D. ^{[9
]}

Jin, X. ^{[9
]}

Wang, Z. M. ^{[9
]}

Li, B. ^{[9
]}

机构：

[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Hangzhou, Peoples R China

[2] Shanghai Chest Hosp, Dept Oncol, Shanghai, Peoples R China

[3] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China

[4] Shanghai Canc Ctr, Dept Radiotherapy, Shanghai, Peoples R China

[5] Adelaide Canc Ctr, Dept Oncol, Kurralta Pk, Australia

[6] Icon Canc Ctr, Dept Oncol, Brisbane, Qld, Australia

[7] Univ Western Sydney, Sch Med, Dept Oncol, Liverpool, Australia

[8] Albury Wodonga Reg Canc Ctr, Dept Oncol, Albury, NSW, Australia

[9] Akeso Biopharma Inc, Zhongshan, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.10.518

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

31P

引用

页码：S1428 / S1429

页数：2

共 50 条

[31] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
Justin C. Kao
Adipong Brickshawana
Teerin Liewluck
Current Neurology and Neuroscience Reports, 2018, 18
[32] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
Kao, Justin C.
Brickshawana, Adipong
Liewluck, Teerin
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
[33] Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy
Naqash, A. R.
Stroud, C. R. G.
Cherry, C.
Muzaffar, M.
Bowling, M.
Walker, P. R.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1559 - S1559
[34] Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma
Daneshmandi, Saeed
Wegiel, Barbara
Seth, Pankaj
CANCERS, 2019, 11 (04):
[35] A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy: Updated results
Chen, X.
Hu, C.
Wang, W.
Zou, Q.
Li, J.
Lin, Q.
Zhu, X.
Jiang, Y.
Sun, Y.
Shen, L.
Wang, L.
Zou, G.
Lin, X.
Wang, Y.
Lin, S.
Li, M.
Ao, R.
Xu, R.
Lin, H.
Wang, R.
ANNALS OF ONCOLOGY, 2021, 32 : S806 - S806
[36] Smoking-Related Outcomes of Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy: A Single Institution Study
Hafiz, M.
Naqash, A. R.
Stroud, C. R. G.
Bowling, M.
Walker, P. R.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1568 - S1569
[37] Discovery and pharmacological characterization of JNJ-63723283, an anti-programmed cell death protein-1 (PD-1) antibody that blocks PD-1 function
Ferrante, Catherine
DeAngelis, Nikki
Powers, Gordon
Sendecki, Jocelyn
Millar, Hillary
Mattson, Bethany
Pizutti, Darlene
Mayer, Christina Lourdes
Wang, Weirong
Brittingham, Raymond
Wheeler, John
Barone, Linda
Nanjunda, Rupesh
Lacy, Eilyn R.
Wu, Sheng-Jiun
Luo, Jinquan
Zudaire, Enrique
Packman, Kathryn
Geist, Brian
Trouba, Kevin
Lorenzi, Matthew V.
Verona, Raluca I.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[38] Sick sinus syndrome associated with anti-programmed cell death-1
Hsu, Chien-Yi
Su, Yu-Wen
Chen, San-Chi
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[39] Anti-programmed cell death-1 therapy in nonmelanoma skin cancer
Winkler, J. K.
Schneiderbauer, R.
Bender, C.
Sedlaczek, O.
Froehling, S.
Penzel, R.
Enk, A.
Hassel, J. C.
BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) : 498 - 502
[40] EFFICACY AND SAFETY OF SERPLULIMAB, A NOVEL ANTI-PROGRAMMED DEATH-1 ANTIBODY, IN CHRONIC HEPATITIS B PATIENTS
Peng, Cheng-Yuan
Dai, Chia-Yen
Kao, Jia-Horng
Yang, Futang
Wang, Qingyu
Zhu, Jun
GUT, 2022, 71 : A12 - A13

← 1 2 3 4 5 →